Antibodies against BACE1 and use thereof for neural disease immunotherapy
US10882920B2 · kind B2 · utility
0Cited by
41References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 18, 2015 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | Nov 18, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides antagonistic antibodies to BACE1 and methods of using the same for the treatment of neurological disease and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.